Dr. Leila Alexander
I am a medical engineer by training (MEng London, 2009). Having a strong interest in drug discovery, I obtained my DPhil at the University of Oxford with main supervisors Stefan Knapp (SGC, Oxford) and Sandra Jacob (Novartis, Basel). My research was focused on understanding how conformational changes in protein kinases can affect catalysis and inhibitor binding of these important drug targets.
I have joined the Zamboni-Sauer group in 2014 to use metabolomics methods in order to investigate the mechanisms of cancer drug resistance. In doing so, I will closely collaborate with AstraZeneca.